MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed the Investors Presentation (Q1' FY21) August, 2020, based on the financial performance of the Company for the quarter ended 30" June, 2020. Kindly acknowledge the receipt and take it on your record. MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the press release on the financial performance of the Company for the quarter ended 30th June, 2020 with the title - 'Morepen Labs' Net Profit rises by 153 percent led by strong API business in Q1'FY 2020-21''. Kindly acknowledge the receipt and take it on your record. MOREPEN LABORATORIES LTD. - 500288 - Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2020
The Board of Directors of the Company, in their meeting held on Monday, 31st August, 2020 (commenced at 12.00 Noon and concluded at 01.30 P.M.), have, inter-alia, considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30th June, 2020, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. MOREPEN LABORATORIES LTD. - 500288 - Outcome Of Board Meeting
This is to inform you that the Board of Directors of the Company, in their meeting held on Monday, 31st August, 2020 (commenced at 12.00 Noon and concluded at 01.30 P.M.), have, inter-alia, considered and approved (1) The unaudited standalone and consolidated financial results of the Company for the quarter ended 30th June, 2020, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the Company for the quarter ended 30th June, 2020 is enclosed herewith. (2) Expansion of APIs (bulk drugs) manufacturing capacity. MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that subsequent to the declaration of unaudited standalone and consolidated financial results for the quarter ended 30th June, 2020, the Company is organizing an 'Investors and Analyst Conference Call' on Tuesday, 1st September, 2020 at 03.00 P.M. (IST). The details of the conference call are attached herewith. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates of the Company MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates and issue of duplicate share certificates by the Company MOREPEN LABORATORIES LTD. - 500288 - Board Meeting Intimation for Approval Of The Un-Audited Financial Results For The Quarter Ended June 30,2020
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2020 ,inter alia, to consider and approve the Un-audited Financial Results of the Company for the Quarter ended 30th June, 2020. MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates of the Company MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates and issue of duplicate share certificates by the Company